Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer

By Bolton D.   Ta A.   Bagnato M.   Muller D.   Lawrentschuk N.   Severi G.   Syme R.   Giles G.  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 431-435

Springer Publishing Company

Access to resources Recommend Favorite

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

By Dillioglugil O.   Leibman B.D.   Kattan M.W.   Seale-Hawkins C.   Wheeler T.M.   Scardino P.T.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

Assessment of Clinical and Pathologic Characteristics Predisposing to Disease Recurrence Following Radical Prostatectomy in Men with Pathologically Organ-Confined Prostate Cancer

By Palisaar R.-J.   Graefen M.   Karakiewicz P.I.   Hammerer P.G.   Huland E.   Haese A.   Fernandez S.   Erbersdobler A.   Henke R.-P.   Huland H.  

European Urology, Vol. 41, Iss. 2, 2002-02 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

By Ung J.O.   Richie J.P.   Chen M.-H.   Renshaw A.A.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 458-463

Elsevier

Access to resources Recommend Favorite